Low-molecular-weight-heparin increases Th1- and Th17-associated chemokine levels during pregnancy in women with unexplained recurrent pregnancy loss: a randomised controlled trial

Low-molecular-weight heparin (LMWH) is widely used to treat recurrent pregnancy loss (RPL) because of its anti-coagulant effects. Although in vitro studies have suggested additional immunological effects, these are debated. We therefore investigated whether LMWH could modulate immune responses in vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmark Roepke, E., Bruno, V., Nedstrand, E., Boij, R., Strid, C. Petersson, Piccione, E., Berg, G., Svensson-Arvelund, J., Jenmalm, M. C., Rubér, M., Ernerudh, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707182/
https://www.ncbi.nlm.nih.gov/pubmed/31444404
http://dx.doi.org/10.1038/s41598-019-48799-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707182/
https://www.ncbi.nlm.nih.gov/pubmed/31444404
http://dx.doi.org/10.1038/s41598-019-48799-6

Ejemplares similares